Scientists from VanderBilt University Medical Center increased two to twelve times that mutations in the WNT9B gene were associated with prostate cancer risk. As a result of research published In JCO Precision oncology.
Such a relationship was confirmed during five independent studies, where approximately 500 thousand volunteers from the US and Europe are involved.
Jeffrey Smith Genetic Medicine Department of Medical Sciences, Associate Prostate Cancer developed a relatively few genes have been identified, “he said. According to scientists, they include HOXB13, BRCA2 and 8q24. The 8Q24 Genomic Zone is also associated with the risk of development of malignant tumors of the colon and breast gland.
Researchers said that the “new” WNT9B gene is designed for the normal development of the prostate gland in the embryos, but that the wrong work in adults could lead to cancer. Scientists, in future research, hereditary or acquired mutation, personalized treatment will allow the clinical outcome of the disease and the course will not affect the course, he added.
Previously, scientists learnedHow cancer cells “hide” from the immune system.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.